How many employees does Rigel Pharmaceuticals, Inc. have?

Rigel Pharmaceuticals, Inc. reported 172 employees for the fiscal year ending Dec 2025, in the annual report it filed on March 3, 2026. That is up 6.2% from a year earlier.

What is Rigel Pharmaceuticals, Inc.'s revenue per employee?

Rigel Pharmaceuticals, Inc. brought in $294M of revenue in fiscal Dec 2025, which is $1.71M per employee. That ranks 14 of 108 companies we track in Biotechnology, where the median is $459K.

Where do these numbers come from?

Employee counts and revenue are taken from each company's own annual report (Form 10-K). Open roles are counted from the company's public job board where we have matched one. Companies report headcount once a year, sometimes rounded, so small changes can be noise.

Company data

Rigel Pharmaceuticals, Inc. employees and revenue per employee

RIGL · Biotechnology · $908M market cap

Rigel Pharmaceuticals, Inc. had 172 employees at the end of fiscal Dec 2025, up 6.2% from a year earlier. Revenue for the year was $294M, up 64.1% from a year earlier, or $1.71M per employee. Revenue and headcount both grew, and revenue grew faster.

Employees

172

+6.2% YoY

Revenue

$294M

+64.1% YoY

Revenue / employee

$1.71M

Peer median $459K

Rank in industry

14 of 108

Biotechnology

Headcount against revenue

Both lines start at 100 in the first year we hold, so you can see which one grew faster.

EmployeesRevenueIndexed to 100 in Dec 2016

Hover a year for the numbers.

RIGL employees and revenue by fiscal year
Year ending	Employees	Revenue	Per employee	Staff YoY	Revenue YoY
Dec 2025	172	$294M	$1.71M	+6.2%	+64.1%
Dec 2024	162	$179M	$1.11M	+10.2%	+53.4%
Dec 2023	147	$117M	$795K	-5.2%	-2.8%
Dec 2022	155	$120M	$776K	-6.1%	-19.4%
Dec 2021	165	$149M	$904K	-2.4%	+37.4%
Dec 2020	169	$109M	$643K	+3.7%	+83.2%
Dec 2019	163	$59.3M	$364K	+3.2%	+33.2%
Dec 2018	158	$44.5M	$282K	+53.4%	+892.6%
Dec 2017	103	$4.5M	$44K	+33.8%	-78.0%
Dec 2016	77	$20.4M	$265K	—	—

Open roles: we have not matched a verified job board for this company yet.

Employees, last six fiscal years

Revenue per employee, last six fiscal years

Rigel Pharmaceuticals, Inc. against similar companies

The closest industry peers by revenue, from Biotechnology.

Company	Employees	Revenue	Revenue / employee	Shape
LGND Ligand Pharmaceuticals Incorporated	47	$268M	$5.70M	Leaner
RIGL Rigel Pharmaceuticals, Inc.	172	$294M	$1.71M	Efficient growth
CRMD CorMedix Inc.	191	$312M	$1.63M	Efficient growth
ARVN Arvinas, Inc.	246	$263M	$1.07M	Contracting
VCEL Vericel Corporation	398	$276M	$694K	Efficient growth
XERS Xeris Biopharma Holdings, Inc.	435	$292M	$671K	Efficient growth
ADPT Adaptive Biotechnologies Corporation	624	$277M	$444K	Efficient growth
RCUS Arcus Biosciences, Inc.	601	$247M	$411K	Contracting
IOVA Iovance Biotherapeutics, Inc.	975	$264M	$270K	Efficient growth

Every Healthcare company

Questions about Rigel Pharmaceuticals, Inc.

How many employees does Rigel Pharmaceuticals, Inc. have?: Rigel Pharmaceuticals, Inc. reported 172 employees for the fiscal year ending Dec 2025, in the annual report it filed on March 3, 2026. That is up 6.2% from a year earlier.
What is Rigel Pharmaceuticals, Inc.'s revenue per employee?: Rigel Pharmaceuticals, Inc. brought in $294M of revenue in fiscal Dec 2025, which is $1.71M per employee. That ranks 14 of 108 companies we track in Biotechnology, where the median is $459K.
Where do these numbers come from?: Employee counts and revenue are taken from each company's own annual report (Form 10-K). Open roles are counted from the company's public job board where we have matched one. Companies report headcount once a year, sometimes rounded, so small changes can be noise.

Free game

Think you can pick better than the S&P 500?

Pick 15 stocks, lock them in, and we score them against the index every trading day for ten years. Free, with a public leaderboard.

Enter the challenge

More data

Compare RIGL with the rest of the market

See who earns the most per employee, who is hiring, and who is cutting, across every company we track.

Leaderboard Healthcare

Source: employee counts and revenue as stated in Rigel Pharmaceuticals, Inc.'s annual reports (Form 10-K), latest filed March 3, 2026. This is data, not a recommendation to buy or sell RIGL.